Fulcrum Therapeutics, Inc. (FULC): Shares Outstanding
66.58M
As of 2025-12-31
76.29M
As of 2026-06-30
+8.5%
3-year compound annual growth
| Period ended | Shares Outstanding | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 66.58M | +23.4% | 2026-02-24, Balance as of period end |
| 2024-12-31 | 53.97M | -12.8% | 2026-02-24, Balance as of period end |
| 2023-12-31 | 61.92M | +18.8% | 2025-02-25, Balance as of period end |
| 2022-12-31 | 52.10M | +28.2% | 2024-02-27, Balance as of period end |
| 2021-12-31 | 40.63M | n/c | 2023-06-26, Balance as of period end |
| 2020-12-31 | 27.94M | +23.3% | 2023-06-26, Balance as of period end |
| 2019-12-31 | 22.65M | n/m | 2023-06-23, Balance as of period end |
| 2018-12-31 | 1.59M | n/a | 2020-03-05, Balance as of period end |